We compared p53 wild-type NSCLC cell lines that express high RBL2 and low AURKA/B pathway genes with cell lines that express low RBL2 and high AURKA/B pathway genes for their sensitivity to PTX and IR. This evidence concerns the gene TP53 and non-small cell lung carcinoma.